Skip to content
Pau D’Arco at a Glance
Handroanthus impetiginosus, commonly called pau d’arco, taheebo or lapacho, is a South American tree in the Bignoniaceae family. Older herbal and scientific literature commonly uses Tabebuia impetiginosa or Tabebuia avellanedae; current botanical systems place the species in Handroanthus. The inner bark has a long history in South American traditional medicine.
Names & Plant Part
The familiar names pau d’arco, taheebo and lapacho can be used broadly in commerce, so correct botanical identification matters. Traditional preparations are associated mainly with the inner bark rather than the outer bark, leaves or flowers. Because several related trees have been sold under similar common names, species verification is important when comparing research or commercial products.
Traditional Use
South American traditional medicine has used pau d’arco bark for a wide range of complaints, including infections, fever, inflammation, digestive problems, skin concerns and general restorative purposes. These uses vary by region and tradition. They are historically important but do not establish that pau d’arco cures infection, cancer or other diseases.
Phytochemistry
Pau d’arco contains naphthoquinones and related compounds, including lapachol and beta-lapachone, along with additional quinones, phenolics and other plant constituents. These compounds have attracted substantial laboratory interest because they can affect microbial growth, inflammatory pathways, cell signaling and cancer-cell models. The amount and balance of these constituents can vary by species, bark source and extraction method.
Cancer Claims & Human Evidence
Pau d’arco is often marketed online as an anticancer herb, but the strongest evidence behind that claim comes from laboratory research on isolated compounds rather than successful clinical treatment with whole bark. Lapachol was investigated in early human cancer research, but dose-limiting toxicity and lack of convincing therapeutic benefit prevented it from becoming an established anticancer treatment. Laboratory activity of beta-lapachone and related compounds is scientifically interesting, but it does not mean pau d’arco tea or supplements have been proven to treat cancer.
Antimicrobial & Anti-Inflammatory Research
Laboratory and animal studies have reported antimicrobial, antifungal, anti-inflammatory and antioxidant effects from pau d’arco extracts and isolated naphthoquinones. These findings help explain continued research interest, but controlled human trials are sparse. Results from test tubes, animals or purified compounds should not be presented as proof that whole-bark preparations treat bacterial, fungal, viral or inflammatory disease in people.
Preparation & Product Differences
Traditional bark decoctions, commercial capsules, concentrated extracts and purified lapachol or beta-lapachone are not interchangeable. Their chemical concentrations and safety profiles differ substantially. Because a reliable therapeutic dose has not been established by strong human trials, this article does not provide a medicinal dosing formula.
Safety & Drug Interactions
Concentrated pau d’arco products can cause nausea, vomiting, diarrhea and other gastrointestinal effects. Naphthoquinone-rich preparations may also affect blood clotting, creating concern for people using anticoagulant or antiplatelet medicines or those with bleeding disorders. Concentrated use should be stopped before planned surgery unless a qualified clinician advises otherwise. Anyone using prescription medicines with bleeding or clotting effects should discuss pau d’arco with a clinician or pharmacist before use.
Pregnancy & Breastfeeding
Medicinal use should be avoided during pregnancy, while trying to conceive and during breastfeeding because reliable safety data are lacking and lapachol-related compounds have shown reproductive and embryo-toxic effects in experimental research. Traditional use does not override these safety concerns.
Bottom Line
Handroanthus impetiginosus, still widely recognized under the older name Tabebuia impetiginosa, is a genuine South American traditional bark medicine with interesting naphthoquinone chemistry. Its anticancer, antimicrobial and anti-inflammatory reputation is much stronger in laboratory research than in human clinical evidence. Historical lapachol cancer studies did not establish an effective treatment and raised toxicity concerns. Pau d’arco should therefore be presented as a traditional and research-interest herb, not as a proven cancer or infection therapy. For educational purposes only.